C3-PMP22 mice, which carry 3–4 copies of the human PMP22 gene, develop a slowly progressive dysmyelinating peripheral neuropathy that is thought to be an appropriate model of CMT1A [25, 26]. This evidence concerns the gene PMP22 and peripheral neuropathy.